A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
Public ClinicalTrials.gov record NCT02963766. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of the study drug dulaglutide compared to placebo in pediatric participants with type 2 diabetes. The study duration is approximately 60 weeks.
Study identification
- NCT ID
- NCT02963766
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 154 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 10 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 29, 2016 (Actual)
- Primary completion
- Jun 12, 2021 (Actual)
- Completion
- Jan 12, 2022 (Actual)
- Last update posted
- Jul 1, 2022
2016 – 2022
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama Birmingham | Birmingham | Alabama | 35233 | — |
| University of Arizona | Tucson | Arizona | 85724 | — |
| Advanced Research Center | Anaheim | California | 92805 | — |
| Division of Endocrinology, Diabetes, and Metabolism | Los Angeles | California | 90027 | — |
| Childrens Hospital of Orange County | Orange | California | 92868 | — |
| Center of Excellence in Diabetes & Endocrinology | Sacramento | California | 95821 | — |
| Rady Childrens Hospital - San Diego | San Diego | California | 92123 | — |
| JC Cabaccan | San Jose | California | 95148 | — |
| Touro University | Vallejo | California | 94592 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| Florida Center for Endocrinology & Metabolism | Orlando | Florida | 32803 | — |
| St. Luke's Regional Medical Center | Boise | Idaho | 83712 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| Indiana University Health Hospital | Indianapolis | Indiana | 46202 | — |
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808-4124 | — |
| Children's Mercy Hospital | Kansas City | Missouri | 64108 | — |
| ECU Pediatric Specialty Care | Greenville | North Carolina | 27834 | — |
| Cincinnati Childrens Hospital Medical Center | Cincinnati | Ohio | 45229 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Childrens Hospital of Pittsburgh | Pittsburgh | Pennsylvania | 15224 | — |
| Seattle Children's Hospital Research Foundation | Seattle | Washington | 98105 | — |
| Multicare Health System | Tacoma | Washington | 98405 | — |
| CAMC Institute | Charleston | West Virginia | 25302 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02963766, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2022 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02963766 live on ClinicalTrials.gov.